Arvinas, Inc. (ARVN) stock
ARVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 8/30
$6.76−0.06 (-0.81%)
Close on Nov 18, 2026Market cap $442.34MP/E 42.3Yield –
Arvinas operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Arvinas's operating cash flow for the twelve months ending Jun 30, 2026 was -$207.00M. For fiscal 2025 it was -$273.80M. The highest annual figure on record is $559.40M in fiscal 2021.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$273.80M | – |
| FY2024 | Dec 31, 2024 | -$259.30M | – |
| FY2023 | Dec 31, 2023 | -$347.80M | – |
| FY2022 | Dec 31, 2022 | -$273.50M | -148.9% |
| FY2021 | Dec 31, 2021 | $559.40M | – |
| FY2020 | Dec 31, 2020 | -$89.70M | – |
| FY2019 | Dec 31, 2019 | -$40.60M | – |
| FY2018 | Dec 31, 2018 | -$16.12M | -415.2% |
| FY2017 | Dec 31, 2017 | $5.11M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$48.30M | – |
| Q1 FY2026 | Mar 31, 2026 | -$69.20M | – |
| Q4 FY2025 | Dec 31, 2025 | -$30.40M | – |
| Q3 FY2025 | Sep 30, 2025 | -$59.10M | – |
| Q2 FY2025 | Jun 30, 2025 | -$95.40M | -289.7% |
| Q1 FY2025 | Mar 31, 2025 | -$88.90M | – |
| Q4 FY2024 | Dec 31, 2024 | -$84.10M | – |
| Q3 FY2024 | Sep 30, 2024 | -$128.00M | – |
| Q2 FY2024 | Jun 30, 2024 | $50.30M | – |
| Q1 FY2024 | Mar 31, 2024 | -$97.50M | – |
| Q4 FY2023 | Dec 31, 2023 | -$83.10M | – |
| Q3 FY2023 | Sep 30, 2023 | -$84.80M | – |
| Q2 FY2023 | Jun 30, 2023 | -$88.70M | – |
| Q1 FY2023 | Mar 31, 2023 | -$91.20M | – |
| Q4 FY2022 | Dec 31, 2022 | -$71.20M | – |
| Q3 FY2022 | Sep 30, 2022 | -$66.60M | -109.8% |
| Q2 FY2022 | Jun 30, 2022 | -$78.60M | – |
| Q1 FY2022 | Mar 31, 2022 | -$57.10M | – |
| Q4 FY2021 | Dec 31, 2021 | -$35.70M | – |
| Q3 FY2021 | Sep 30, 2021 | $681.50M | – |
| Q2 FY2021 | Jun 30, 2021 | -$47.40M | – |
| Q1 FY2021 | Mar 31, 2021 | -$39.00M | – |
| Q4 FY2020 | Dec 31, 2020 | -$28.96M | – |
| Q3 FY2020 | Sep 30, 2020 | -$22.38M | -1307.6% |
| Q2 FY2020 | Jun 30, 2020 | -$21.40M | – |
| Q1 FY2020 | Mar 31, 2020 | -$16.95M | – |
| Q4 FY2019 | Dec 31, 2019 | -$16.15M | – |
| Q3 FY2019 | Sep 30, 2019 | $1.85M | – |
| Q2 FY2019 | Jun 30, 2019 | -$13.57M | – |
| Q1 FY2019 | Mar 31, 2019 | -$12.73M | -166.0% |
| Q4 FY2018 | Dec 31, 2018 | -$12.25M | -143.5% |
| Q3 FY2018 | Sep 30, 2018 | -$10.99M | – |
| Q2 FY2018 | Jun 30, 2018 | -$12.18M | – |
| Q1 FY2018 | Mar 31, 2018 | $19.30M | – |
| Q4 FY2017 | Dec 31, 2017 | $28.16M | – |
See a number that looks wrong?